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Abstract
Purpose To investigate the process of bacterial invasion
from the surface to inside prosthetic vascular grafts.
Methods Elastomer-sealed Dacron vascular grafts (ES-
DVGs) and gelatin-coated Dacron vascular grafts
(GCDVGs) were cut into 6-cm segments and placed in a U-
shaped configuration on culture plates. Physiological saline
was poured inside the grafts and a suspension of Pseudo-
monas aeruginosa was added to the outside. Samples taken
from inside the grafts at nine time points for up to 60 h
were spread on agar. Bacterial colonies were then ana-
lyzed. The grafts were also examined using scanning
electron microscopy (SEM).
Results Contaminated vascular graft models were pro-
duced in 18 ESDVGs (group T) and 12 GCDVGs (group
G). The bacterial counts inside the vascular grafts in both
groups increased over time. Bacterial colonies were con-
firmed in all samples from group G by 30 h, whereas
bacteria appeared inside the grafts from group T at various
times between 0 and 60 h. Bacteria were undetectable in
one model from group T throughout the study. SEM
revealed that the elastomeric membrane in the ESDVG was
uneven.
Conclusion Bacterial invasion of vascular grafts does not
always occur immediately after contamination. ESDVGs
may be more resistant to bacterial invasion as they have a
thicker and evenly enriched elastomeric membrane.
Keywords Graft infection  Bacterial invasion 
Elastomer-sealed Dacron vascular graft  Gelatin-
coated Dacron vascular graft  Pseudomonas
aeruginosa
Introduction
Infection of a prosthetic vascular graft is a serious complication,
which can progress to lethal systemic sepsis if treatment is
delayed. Thus, the factors involved in the infectivity of pros-
thetic vascular grafts should be established in relation to bac-
terial adherence [1] and invasion. Regarding bacterial adherence
to vascular grafts [1] and antibiotic-coated grafts [2, 3], some
in vitro and in vivo [4] studies have been published. We
investigated bacterial invasion from the outer surface to the
inside of vascular grafts using a new experimental system
in vitro to consider the relationships between the time required
for invasion and the amount of bacteria inside the grafts. Graft
fragments were also examined using scanning electron
microscopy (SEM). We compared classical gelatin-coated
Dacron vascular grafts (GCDVGs) with new elastomer-sealed
Dacron vascular grafts (ESDVGs) to elucidate the effects of
bacterial invasion on different materials. Increased knowledge
about graft infectivity will assist in the treatment of this refrac-
tory complication and help avoid implanted graft excision.
Methods
The Committee for Biosafety and Biosecurity at Toho
University School of Medicine (Tokyo, Japan) approved
the study protocol. Experiments using virulent bacteria
were carried out in a laboratory at the Department of
Microbiology and Infectious Diseases (School of
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Medicine, Faculty of Medicine, Toho University, Tokyo,
Japan) under the guidance of qualified staff.
Prosthetic vascular grafts
Straight, 8-mm diameter ESDVGs (Triplex, Vascutek
Terumo, Tokyo, Japan) and GCDVGs (Gelweave, Vas-
cutek Terumo, Tokyo, Japan) were cut into 6-cm segments.
Model bacterial strain and suspension
The model bacterium was Pseudomonas aeruginosa strain
PAO1 (ATCC 15692) because of its motility and ability to
thrive in physiological saline. P. aeruginosa frozen at -
80 C was spread on LB agar and incubated for 18 h at
35 C. Resulting bacterial colonies were transferred, using
a sterile loop, into 30 mL of LB broth and incubated for
24 h at 35 C. Thereafter, 3 mL of the LB broth containing
P. aeruginosa was centrifuged at 8,000 rpm for 5 min and
the sediment was resuspended in 30 mL of physiological
saline and used as the bacterial suspension.
The bacterial concentration in the suspensions before the
experiments was confirmed to be approximately 1.0 9 108 col-
onyformingunits (CFU)/mLbyspreading10 lLofeachproperly
diluted bacterial suspension on LB agar and counting the colonies
manually after 18 h of incubation at 35 C. Bacterial suspensions
were maintained by shaking at 160 rpm at 35 C until use.
Study 1: Relationship between time required for
invasion and the density of bacteria inside the vascular
grafts
Models of contaminated vascular grafts
The 18 ESDVG (group T) and 12 GCDVG (group G)
models of contaminated vascular grafts were produced as
follows (Fig. 1): Prosthetic vascular grafts cut into 6-cm
segments were placed in a U-shaped configuration in six-
well culture plates (FALCON, Becton, Dickinson and
Co., Franklin Lakes, NJ, USA). Sterile physiological saline
(2 mL) was poured inside the grafts and bacterial suspen-
sions (5 mL) were added to the area outside the grafts. The
plates were covered and incubated at 35 C until the end of
the study.
Sampling and bacterial counting
Samples (50 lL) collected from the inside of the grafts
using micropipettes were appropriately diluted, spread on
LB agar, and incubated at 35 C for 18 h. Bacterial colo-
nies were then manually counted. Samples were collected
every 6 h for 36 h, and then 48 and 60 h from inside, and 0,
24, 48 and 60 h from outside the grafts. Bacterial counts
are expressed as CFU/mL and were converted into log
CFU/mL for statistical analysis. The limit of bacterial
detection was 2.0 9 101 CFU/mL.
Statistical analysis
Arithmetic data are expressed as mean ± standard devia-
tion and were statistically analyzed using JMP 9.0.3 (SAS
Institute Inc., Cary, NC, USA). Bacterial counts inside and
outside the vascular grafts at each time point between two
groups were evaluated using the Mann–Whitney U test.
The time elapsed before bacteria appeared inside the vas-
cular grafts was calculated from Kaplan–Meier curves and
then values were compared between the groups using the
log-rank test. A P value \ 0.05 was considered to indicate
a significant difference.
Study 2: Observations of prosthetic vascular grafts by
SEM
An S-3500N Scanning Electron Microscope (Hitachi Ltd.,
Tokyo, Japan) was used to examine the structures of fresh
ESDVGs and GCDVGs and determine the degrees of
invasion of the graft walls at various angles after incuba-
tion for 60 h during the study 1 in suspensions of P.
aeruginosa.
Sample processing for SEM
Vascular grafts were fixed in 2.0 % glutaraldehyde for
48 h, rinsed in physiological saline, fixed with 2.0 %
osmium tetroxide for 2 h, irrigated with distilled water and
then dehydrated in a graded series of 50–100 % ethanol.
They were then placed in tertiary-butyl alcohol and dried in
an ES-2030 critical-point dryer (Hitachi Ltd., Tokyo,
Japan). Dried grafts were trimmed, mounted onto SEM
Fig. 1 Establishment of contaminated vascular graft models
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slabs at various angles and sputter-coated with platinum-
vanadium for 80 s using an Ion Sputter E-1030 (Hitachi
Ltd., Tokyo, Japan). Graft structures and degrees of bac-
terial invasion were investigated as described above in
long-axis and short-axis views.
Results
Study 1
Bacteria started to invade the GCDVG from 6 h post-
immersion and all samples from inside the GCDVGs had
generated bacterial colonies by 30 h. The average elapsed
time until bacteria appeared inside the GCDVGs was
15.5 ± 7.0 h. Bacteria were identified inside two ESDVGs
immediately after immersion, and in one model after
60 h. Bacteria remained undetectable in another model
Table 1 Average bacterial counts outside the vascular grafts
Bacterial counts (log CFU/mL)
Elapsed time (h)a Group G Group T
0 7.0 ± 0.4 7.2 ± 0.6 NS
24 7.5 ± 0.3 7.3 ± 0.4 NS
48 7.5 ± 0.3 7.6 ± 0.3 NS
60 7.7 ± 0.2 7.7 ± 0.4 NS
Bacterial counts are expressed as mean ± standard deviation
Mann–Whitney U test of data at each time point revealed no signif-
icant differences (NS) between group T (ESDVG group) and group G
(GCDVG group)
a Hours after establishing models of contaminated vascular grafts
Table 2 Average bacterial counts inside the vascular grafts
Bacterial counts (log CFU/mL)
Elapsed time (h)a Group G Group T
0 0 0.1 ± 0.4 NS
6 0.3 ± 0.6 1.2 ± 1.5 NS
12 1.0 ± 1.1 1.2 ± 1.7 NS
18 2.6 ± 1.5 1.8 ± 2.0 NS
24 3.6 ± 1.4 2.4 ± 2.3 NS
30 4.4 ± 0.9 3.4 ± 2.3 NS
36 4.6 ± 1.1 3.8 ± 2.4 NS
48 4.9 ± 1.0 4.1 ± 2.5 NS
60 5.1 ± 1.0 4.5 ± 2.5 NS
Bacterial counts are expressed as mean ± standard deviation
Mann–Whitney U test of data at each time point revealed no signif-
icant differences (NS) between group T (ESDVG group) and group G
(GCDVG group)
a Hours after establishing models of contaminated vascular grafts
Fig. 2 Vertical axis shows ratio of models in which bacteria were
undetectable inside vascular grafts. The horizontal axis shows elapsed
time. Bacteria were detected inside grafts in all models of group G
(GCDVG group) by 30 h. Bacteria were undetectable throughout the
study in one model from group T (ESDVG group). However, log-rank
test did not reveal any significant differences between the two groups
Fig. 3 a Scanning electron microscopy finding of sterile gelatin-
coated Dacron vascular graft. Short-axis view of gelatin-coated
Dacron vascular graft shows woven Dacron structure (magnification
950). b Scanning electron microscopy finding of sterile elastomer-
sealed Dacron vascular graft. Short-axis view of elastomer-sealed
Dacron vascular graft shows unique three-layer structure comprising a
central elastomeric membrane sandwiched between layers of knitted
Dacron (magnification 950)
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throughout the study. The average time taken for bacteria
to become detectable inside the ESDVGs was
22.0 ± 19.7 h.
Bacterial counts inside the grafts increased over time in
both groups. Bacterial counts outside (Table 1) and inside
(Table 2) the vascular grafts at each time point did not
differ significantly between the groups (P [ 0.05, Mann–
Whitney U test). The time that elapsed before bacteria
appeared inside the vascular grafts was determined from
Kaplan–Meier curves (Fig. 2). Values did not differ sig-
nificantly between the groups (P [ 0.05, log-rank test).
Study 2
Figure 3a, b shows short-axis SEM views of a sterile
GCDVG and ESDVG, respectively. The wall of the ES-
DVG comprised a central, low-porosity elastomeric
membrane sandwiched between outer and inner layers of
knitted Dacron. The elastomeric membrane was proved to
have uneven thickness and the thinnest portion was about
2 lm (Fig. 4a). Defects were also evident in the membrane
(Fig. 4b). The uneven thickness and defects in the
elastomeric membrane might have been associated with the
time required for the bacteria to invade the ESDVG.
SEM views of grafts inoculated with P. aeruginosa for
60 h revealed bacteria in gaps between the GCDVG fibers
(Fig. 5a) and in the elastomeric membrane of the ESDVGs
(Fig. 5b).
Discussion
The model bacterial species in this study was P. aeruginosa
because of its motility and ability to exist in physiological
saline. Although it is not a typical bacterium found in
vascular graft infection, there are reports of aortic aneurysm
and prosthetic vascular graft infections caused by P. aeru-
ginosa [5–7]. Furthermore, the indications for major aortic
and peripheral vascular surgery have recently been exten-
ded to include high-risk patients, making the incidence of
infection caused by P. aeruginosa likely to increase. In fact,
it has already become a serious issue, especially during the
vascular surgery [8]. Thus, vascular graft infection caused
by this organism should be investigated.
Fig. 4 a Scanning electron microscopy findings of sterile elastomer-
sealed Dacron vascular grafts. Short-axis views at 9300 (left) and
9200 (right) magnification show uneven thickness of elastomeric
membrane. Arrows: a, 50 lm; b, 150 lm; c, 2 lm; d, 300 lm. b
Scanning electron microscopy findings of sterile elastomer-sealed
Dacron vascular grafts. Short-(left) and long-(right) axis views at
magnification of 9200 and 9300, respectively, show defects in
elastomeric membrane (arrows)
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The new ESDVG used in the present study has a unique
structure comprising a central elastomeric membrane
sandwiched between two layers of high-porosity knitted
Dacron [9, 10]. The elastomeric membrane consists of a
highly flexible styrene polymer with a low-porosity mate-
rial. The porosity of the ESDVG is significantly lower than
that of standard coated grafts, preventing water leakage [9].
Accordingly, I postulated that the ESDVG would be more
resistant to bacterial invasion than standard coated vascular
grafts when exposed to direct external bacterial contami-
nation. I selected gelatin-coated woven Dacron vascular
grafts to compare with the ESDVGs. In the clinical setting,
gelatin-coated woven Dacron grafts are used more fre-
quently than knitted Dacron grafts due to enlargement of
the diameter during the postoperative course [11]. Coated
knitted Dacron vascular grafts are not used in our institu-
tion even for surgery on the abdominal aorta. The present
study investigated only vascular grafts that are applied in
clinical medicine.
Although no significant differences were identified
between the two types of grafts, the time that elapsed
before bacteria appeared inside the ESDVGs ranged from 0
to 60 h and SEM confirmed thin areas and defects in the
elastomeric membrane of the sterile ESDVGs. These fea-
tures might have been associated with the immediate
appearance of bacteria inside the ESDVG. The thinner
areas and defects in the elastomeric membrane may have
facilitated bacterial invasion. If so, this could be prevented
by thickening and enriching the elastomeric membrane.
No bacterium was confirmed in samples from inside the
GCDVGs at 0 h. According to experimental data presented
by Terumo Corporation (Tokyo, Japan), which simulates
14 days of in vivo hydrolysis, the gelatin remaining rates
on the grafts are about 100, 90, 80, 70, and 5 % on days 0,
2, 4, 7, and 14, respectively. Although my experiment is
in vitro, basic research, time and the amount of bacterial
invasion into vascular graft would be minimally affected
by the hydrolysis rate of the gelatin sealant. The present
Fig. 5 a Scanning electron microscopy views of gelatin-coated
Dacron vascular graft after immersion in Pseudomonas aeruginosa
suspension for 60 h. There are long-axis views of the fragment of
gelatin-coated Dacron vascular graft at magnification of 9270 (left)
and 91000 (right). Many bacteria are evident in gaps between graft
fibers at 91000 magnification. b Scanning electron microscopy views
of elastomer-sealed Dacron vascular graft after immersion in
Pseudomonas aeruginosa suspension for 60 h. There are short-axis
views of elastomeric membrane in fragment of elastomer-sealed
Dacron vascular graft at magnification of 91500 (left) and 94000
(right). Bacteria are evident in elastomeric membrane (arrows)
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in vitro results also indicate that bacterial invasion into
vascular grafts is not always immediate, even if the grafts
are located in a highly contaminated area. As bacterial
counts inside vascular grafts would increase over time,
prosthetic vascular grafts implanted in infected wounds
should be drained and irrigated as soon as possible to
prevent systemic sepsis and graft removal in the clinical
setting. Recent clinical efforts have been made to preserve
infected prosthetic vascular grafts. Dosluoglu and col-
leagues [12] argue that patients with exposed grafts after
inguinal wound dehiscence without systemic sepsis can be
treated by graft preservation treatment such as negative
pressure wound therapy (NPWT). Under probable con-
taminated conditions such as traumatic disease or infected
aneurysms, vascular grafts should be made resistant to
bacterial invasion by sufficient irrigation and the insertion
of a suction drain around them. NPWT at wound dehis-
cence would also help prevent graft infection and systemic
sepsis.
In conclusion, the findings of the present study suggest
that evenly thickening and enriching the elastomeric
membrane of ESDVGs may improve their ability to resist
or suppress bacterial invasion. To my knowledge, this is
the first published investigation of the mechanism of bac-
terial invasion into prosthetic vascular grafts.
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